{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:33:53Z","timestamp":1791988433394,"version":"4.4.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>Melasma is a common chronic, relapsing pigmentary disorder that causes psychological impact. Chemical peels are a well-known therapeutic modality used for accelerating the treatment of melasma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>To review the published evidence on the efficacy and safety of chemical peels in the treatment of melasma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS<\/jats:title>\n            <jats:p>A systematic review was done. A meta-analysis could not be done due to the heterogeneity of data.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULT<\/jats:title>\n            <jats:p>The authors conducted a PubMed search and included prospective case series of more than 10 cases and randomized controlled trials (RCTs) that have studied the safety and\/or efficacy of chemical peel in melasma. Out of 24 studies, 9 were clinical\/comparative trials and 15 were RCTs. The total sample size was 1,075. The duration of the study varied from 8 to 36 weeks. Only 8 studies were split face. All studies used self-assessment, physician global assessment, and Melasma Area and Severity Index (MASI) for quantifying the results. Glycolic acid was found to be the most safe and effective in melasma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>Chemical peels were found to be safe and effective in the management of melasma.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dss.0000000000004167","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T16:00:55Z","timestamp":1711468855000},"page":"656-661","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Chemical Peels for Melasma: A Systematic Review"],"prefix":"10.1097","volume":"50","author":[{"given":"Rashmi","family":"Sarkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ridhima","family":"Lakhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,3,26]]},"reference":[{"key":"R1-20250731","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jaad.2010.12.046","article-title":"Melasma: a comprehensive update: part I","volume":"65","author":"Sheth","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 2","key":"R2-20250731","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2165\/00044011-199500102-00006","article-title":"Melasma in orientals","volume":"10","author":"Sivayathorn","year":"1995","journal-title":"Clin Drug Invest"},{"key":"R3-20250731","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1001\/archderm.143.3.424","article-title":"Prevalence of self-diagnosed melasma among premenopausal Latino women in Dallas and Fort Worth, Tex","volume":"143","author":"Werlinger","year":"2007","journal-title":"Arch Dermatol"},{"key":"R4-20250731","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s40257-019-00488-w","article-title":"Melasma treatment: an evidence-based review","volume":"21","author":"McKesey","year":"2020","journal-title":"Am J Clin Dermatol"},{"key":"R5-20250731","first-page":"918","article-title":"An advanced, physician-strength retinol peel improves signs of aging and acne across a range of skin types including melasma and skin of color","volume":"18","author":"Sadick","year":"2019","journal-title":"J Drugs Dermatol"},{"key":"R6-20250731","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1046\/j.1365-4362.1998.00585.x","article-title":"Treatment of melasma: a review with personal experience","volume":"37","author":"Piamphongsant","year":"1998","journal-title":"Int J Dermatol"},{"key":"R7-20250731","first-page":"828","article-title":"The combination of glycolic acid peels with a topical regimen in the treatment of melasma in dark-skinned patients: a comparative study","volume":"28","author":"Sarkar","year":"2002","journal-title":"Dermatol Surg"},{"key":"R8-20250731","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1001\/archderm.138.12.1578","article-title":"Efficacy of glycolic acid peels in the treatment of melasma","volume":"138","author":"Hurley","year":"2002","journal-title":"Arch Dermatol"},{"key":"R9-20250731","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.jaad.2009.12.027","article-title":"A prospective, randomized, split- face, controlled trial of salicylic acid peels in the treatment of melasma in Latin American women","volume":"63","author":"Kodali","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"R10-20250731","first-page":"385","article-title":"Efficacy of hydroquinone (2%) versus tretinoin (0.025%) as adjunct topical agents for chemical peeling in patients of melasma","volume":"30","author":"Nanda","year":"2004","journal-title":"Dermatol Surg"},{"key":"R11-20250731","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1346-8138.2007.00211.x","article-title":"Efficacy and safety of serial glycolic acid peels and a topical regimen in the treatment of recalcitrant melasma","volume":"34","author":"Erbil","year":"2007","journal-title":"J Dermatol"},{"key":"R12-20250731","first-page":"1149","article-title":"Efficacy of combination of glycolic acid peeling with topical regimen in treatment of melasma","volume":"12","author":"Chaudhary","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"R13-20250731","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/jocd.12260","article-title":"Combination of glycolic acid peel and topical 20% azelaic acid cream in melasma patients: efficacy and improvement in quality of life","volume":"16","author":"Dayal","year":"2017","journal-title":"J Cosmet Dermatol"},{"key":"R14-20250731","first-page":"1032","article-title":"Comparative evaluation of beneficiary effects of priming agents (2% hydroquinone and 0.025% retinoic acid) in the treatment of melasma with glycolic acid peels","volume":"34","author":"Garg","year":"2008","journal-title":"Dermatol Surg"},{"key":"R15-20250731","first-page":"205","article-title":"Comparison of 30% salicylic acid with Jessner's solution for superficial chemical peeling in epidermal melasma","volume":"18","author":"Ejaz","year":"2008","journal-title":"J Coll Physicians Surg Pak"},{"key":"R16-20250731","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1473-2165.2009.00471.x","article-title":"Different therapeutic modalities for treatment of melasma","volume":"8","author":"Azzam","year":"2009","journal-title":"J Cosmet Dermatol"},{"key":"R17-20250731","doi-asserted-by":"crossref","first-page":"447","DOI":"10.4103\/0378-6323.66602","article-title":"Comparative study of trichloroacetic acid versus glycolic acid chemical peels in the treatment of melasma","volume":"76","author":"Kumari","year":"2010","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R18-20250731","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1524-4725.2010.01481.x","article-title":"Glycolic acid peels versus amino fruit acid peels in the treatment of melasma","volume":"36","author":"Ilknur","year":"2010","journal-title":"Dermatol Surg"},{"key":"R19-20250731","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/DSS.0000000000000642","article-title":"Comparative evaluation of efficacy and tolerability of glycolic acid, salicylic mandelic acid, and phytic acid combination peels in melasma","volume":"42","author":"Sarkar","year":"2016","journal-title":"Dermatol Surg"},{"key":"R20-20250731","first-page":"756","article-title":"Tretinoin peels versus glycolic acid peels in the treatment of Melasma in dark-skinned patients","volume":"30","author":"Khunger","year":"2004","journal-title":"Dermatol Surg"},{"key":"R21-20250731","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00042728-200502000-00005","article-title":"Lactic acid as a new therapeutic peeling agent in melasma","volume":"31","author":"Sharquie","year":"2005","journal-title":"Dermatol Surg"},{"key":"R22-20250731","first-page":"1439","article-title":"Comparison between 1% tretinoin peeling versus 70% glycolic acid peeling in the treatment of female patients with melasma","volume":"10","author":"Faghihi","year":"2011","journal-title":"J Drugs Dermatol"},{"key":"R23-20250731","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1097\/DSS.0000000000001964","article-title":"Comparative efficacy of a 35% glycolic acid peel alone or in combination with a 10% and 20% trichloroacetic acid spot peel for melasma: a randomized control trial","volume":"45","author":"Garg","year":"2019","journal-title":"Dermatol Surg"},{"key":"R24-20250731","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/DSS.0000000000001036","article-title":"Combined jessner solution and trichloroacetic acid versus trichloroacetic acid alone in the treatment of melasma in dark-skinned patients","volume":"43","author":"Abdel-Meguid","year":"2017","journal-title":"Dermatol Surg"},{"key":"R25-20250731","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1473-2165.2007.00302.x","article-title":"Combined trichloroacetic acid peel and topical ascorbic acid versus trichloroacetic acid peel alone in the treatment of melasma: a comparative study","volume":"6","author":"Soliman","year":"2007","journal-title":"J Cosmet Dermatol"},{"key":"R26-20250731","first-page":"557","article-title":"Efficacy of trichloro-acetic acid peel alone versus combined topical magnesium ascorbyl phosphate for epidermal melasma","volume":"26","author":"Murtaza","year":"2016","journal-title":"J Coll Phys Surg-Pak"},{"key":"R27-20250731","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1080\/14764172.2017.1314501","article-title":"Salicylic acid peeling combined with vitamin C mesotherapy versus salicylic acid peeling alone in the treatment of mixed type melasma: a comparative study","volume":"19","author":"Balevi","year":"2017","journal-title":"J Cosmet Laser Ther"},{"key":"R28-20250731","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/14764172.2012.655287","article-title":"Split-face comparative study of 1550 nm fractional photothermolysis and trichloroacetic acid 15% chemical peeling for facial melasma in Asian skin","volume":"14","author":"Hong","year":"2012","journal-title":"J Cosmet Laser Ther"},{"key":"R29-20250731","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/14764170902842549","article-title":"Melasma: treatment evaluation","volume":"11","author":"Salem","year":"2009","journal-title":"J Cosmet Laser Ther"},{"key":"R30-20250731","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3109\/09546634.2013.848261","article-title":"A comparative study of low-fluence 1064-nm Q-switched Nd:YAG laser with or without chemical peeling using Jessner's solution in melasma patients","volume":"25","author":"Lee","year":"2014","journal-title":"J Dermatolog Treat"},{"key":"R31-20250731","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jaad.2006.02.009","article-title":"The treatment of melasma: a review of clinical trials","volume":"55","author":"Gupta","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"R32-20250731","first-page":"32","article-title":"Evidence and considerations in the application of chemical peels in skin disorders and aesthetic resurfacing","volume":"3","author":"Rendon","year":"2010","journal-title":"J Clin Aesthet Dermatol"},{"key":"R33-20250731","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.det.2007.04.006","article-title":"Therapeutical approaches in melasma","volume":"25","author":"Prignano","year":"2007","journal-title":"Dermatol Clin"},{"key":"R34-20250731","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.det.2007.04.012","article-title":"New and experimental treatments of cloasma and other hypermelanoses","volume":"25","author":"Picardo","year":"2007","journal-title":"Dermatol Clin"},{"key":"R35-20250731","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/jocd.12444","article-title":"Q-switched Nd: YAG laser alone or with modified Jessner chemical peeling for treatment of mixed melasma in dark skin types: a comparative clinical, histopathological, and immunohistochemical study","volume":"17","author":"Saleh","year":"2018","journal-title":"J Cosmet Dermatol"},{"key":"R36-20250731","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/pcmr.12684","article-title":"Melasma, a photoaging disorder","volume":"31","author":"Passeron","year":"2018","journal-title":"Pigment Cell Melanoma Res"},{"key":"R37-20250731","first-page":"578","article-title":"Chemical peels in melasma: a review with consensus recommendations by Indian pigmentary expert group","volume":"62","author":"Sarkar","year":"2017","journal-title":"Indian J Dermatol"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000004167","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T22:03:49Z","timestamp":1753999429000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000004167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,26]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000004167","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,26]]}}}